IP Library Granted Patent US 11,801,272
Granted Patent B2
US 11,801,272 · App. 17/500,606 · Granted Oct 31, 2023

Patent

Inventors: Derrick Lewis (Durham, NC); Marianne Thorup Cohn (Copenhagen, DK); Adam Nelson (Salem, VA); Preben Nielsen (Horsholm, DK)
Assignee: Novozymes A/S
A61K35/742A23K10/18A23K50/75A61P31/04C12N1/20C12N1/205C12R2001/07
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,801,272
App. No.
17/500,606
Granted
Oct 31, 2023
Kind
B2
Abstract

The present invention relates to Bacillus strains which improves health and performance of production animals. The invention further relates to compositions comprising the Bacillus strains.

Claims (20)

1. A method comprising administering Bacillus subtilis DSM 29870 to an animal.

2. The method of claim 1 , wherein said administering comprises administering spores of Bacillus subtilis DSM 29870 to said animal.

3. The method of claim 1 , wherein Bacillus subtilis DSM 29870 is fed to said animal.

4. The method of claim 2 , wherein Bacillus subtilis DSM 29870 is fed to said animal as part of an animal feed composition.

5. The method of claim 2 , wherein Bacillus subtilis DSM 29870 is fed to said animal as part of a composition comprising between 1×10 4 and 1×10 18 colony forming units of Bacillus subtilis DSM 29870 per kilogram of said composition.

6. The method of claim 2 , wherein Bacillus subtilis DSM 29870 is fed to said animal as part of a composition comprising one or more enzymes.

7. The method of claim 2 , wherein Bacillus subtilis DSM 29870 is fed to said animal as part of a composition comprising one or more feed ingredients.

8. The method of claim 2 , wherein Bacillus subtilis DSM 29870 is fed to said animal as part of a composition comprising one or more vitamins.

9. The method of claim 2 , wherein Bacillus subtilis DSM 29870 is fed to said animal as part of a composition comprising one or more flowability agents.

10. The method of claim 2 , wherein Bacillus subtilis DSM 29870 is fed to said animal as part of a composition comprising one or more additional microbes.

11. The method of claim 2 , wherein Bacillus subtilis DSM 29870 is fed to said animal as part of a composition comprising extruded animal feed pellets.

12. The method of claim 2 , wherein said animal is mono-gastric.

13. The method of claim 2 , wherein said animal is a poultry animal.

14. The method of claim 2 , wherein said animal is a swine animal.

15. The method of claim 2 , wherein Bacillus subtilis DSM 29870 is administered to said animal in an amount sufficient to improve one or more performance parameters of said animal, as compared to that of a control animal that was not administered Bacillus subtilis DSM 29870.

16. The method of claim 2 , wherein Bacillus subtilis DSM 298 is administered to said animal in an amount sufficient to improve body weight gain of said animal, as compared to that of a control animal that was not administered Bacillus subtilis DSM 29870.

17. The method of claim 2 , wherein Bacillus subtilis DSM 29870 is administered to said animal in an amount sufficient to improve a feed conversion ratio of said animal, as compared to that of a control animal that was not administered Bacillus subtilis DSM 29870.

18. The method of claim 2 , wherein Bacillus subtilis DSM 29870 is administered to said animal in an amount sufficient to improve the feed efficiency of said animal, as compared to that of a control animal that was not administered Bacillus subtilis DSM 29870.

19. The method of claim 2 , wherein Bacillus subtilis DSM 29870 is administered to said animal in an amount sufficient to reduce one or more symptoms of Clostridium perfringens infection.

20. The method of claim 2 , wherein Bacillus subtilis DSM 29870 is administered to said animal in an amount sufficient to reduce one or more symptoms of necrotic enteritis.

Continuity (4)
Continuation 15542161
Provisional Application 62260882 · Nov 30, 2015
Provisional Application 62106892 · Jan 23, 2015
Related Publication 20220143110A1 · May 12, 2022